Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BRCA2 Produits

(Breast Cancer 2, Early Onset (BRCA2))
Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, Dec 2008].

antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.

Catégories BRCA2 en vedette

BRCA2 Anticorps

High quality antibodies with extensive validation data.

BRCA2 Kits ELISA

Reliable ELISA kits for a wide range of species.

BRCA2 Protéines

Proteins for various applications incl. WB, ELISA, IF etc.

BRCA2 recommandé Anticorps

Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Application WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro)
Validations
  • (2)
  • (1)
N° du produit ABIN673434
Quantité 100 μL
Fiche technique Fiche technique
Reactivity Human, Rat
Application WB, IHC, IF
Validations
  • (7)
N° du produit ABIN7234156
Quantité 200 μL
Fiche technique Fiche technique
Reactivity Mouse
Application WB, IHC, IP, ICC
Validations
  • (3)
N° du produit ABIN7433543
Quantité 100 μL
Fiche technique Fiche technique

BRCA2 recommandé Kits ELISA

Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Analytical Method Quantitative Sandwich ELISA
Validations
  • (1)
N° du produit ABIN6954189
Quantité 96 tests
Fiche technique Fiche technique
Reactivity Mouse
Analytical Method Quantitative Sandwich ELISA
Validations
  • (1)
N° du produit ABIN6954190
Quantité 96 tests
Fiche technique Fiche technique
Reactivity Human
Analytical Method Quantitative Sandwich ELISA
Validations
N° du produit ABIN511250
Quantité 96 tests
Fiche technique Fiche technique

BRCA2 recommandé Protéines

Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Source Escherichia coli (E. coli)
Validations
  • (1)
N° du produit ABIN7122032
Quantité 50 μg
Fiche technique Fiche technique
Reactivity Human
Source Wheat germ
Validations
  • (1)
N° du produit ABIN1346849
Quantité 10 μg
Fiche technique Fiche technique
Reactivity Human
Source Escherichia coli (E. coli)
Validations
N° du produit ABIN7504959
Quantité 100 μg
Fiche technique Fiche technique

Dernières publications sur nos produits BRCA2

Whelan, Lee, Yin, Ofri, Bermudez-Hernandez, Keegan, Fenyo, Rothenberg: "Spatiotemporal dynamics of homologous recombination repair at single collapsed replication forks." dans: Nature communications, Vol. 9, Issue 1, pp. 3882, (2019) (PubMed).

Chang, Zhang, Chang, Song, Qin, Chang, Guo, Wei: "Expression characteristics of FHIT, p53, BRCA2 and MLH1 in families with a history of oesophageal cancer in a region with a high incidence of oesophageal cancer." dans: Oncology letters, Vol. 9, Issue 1, pp. 430-436, (2015) (PubMed).

Moeller, Yordy, Williams, Giri, Raju, Molkentine, Byers, Heymach, Story, Lee, Sturgis, Weber, Garden, Ang, Schwartz: "DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 17, Issue 7, pp. 2035-43, (2011) (PubMed).

Bernard-Gallon, Dechelotte, Le Corre, Chalabi, Vissac-Sabatier, Bignon: "Differential expressions of BRCA1 and BRCA2 in infantile gynecomastia." dans: Anticancer research, Vol. 24, Issue 1, pp. 321-4, (2004) (PubMed).

Bernard-Gallon, Déchelotte, Vissac, Aunoble, Cravello, Malpuech, Bignon: "BRCA1 and BRCA2 protein expressions in an ovotestis of a 46, XX true hermaphrodite." dans: Breast cancer research : BCR, Vol. 3, Issue 1, pp. 61-5, (2001) (PubMed).

Wu, Jiang, Thangaraju, Wu, Couch: "Induction of the BRCA2 promoter by nuclear factor-kappa B." dans: The Journal of biological chemistry, Vol. 275, Issue 45, pp. 35548-56, (2000) (PubMed).

Sergeeva, Ershova, Veiko, Malinovskaya, Kalyanov, Kameneva, Stukalov, Dolgikh, Konkova, Ermakov, Veiko, Izhevskaya, Kutsev, Kostyuk: "Low-Dose Ionizing Radiation Affects Mesenchymal Stem Cells via Extracellular Oxidized Cell-Free DNA: A Possible Mediator of Bystander Effect and Adaptive Response." dans: Oxidative medicine and cellular longevity, Vol. 2017, pp. 9515809 (PubMed).

Synonymes et noms alternatifs relatifs à BRCA2

BRCA2, DNA repair associated (BRCA2), Breast cancer 2, early onset homolog (Brca2), BRCA2, DNA repair associated (Brca2), breast cancer 2, early onset (brca2), breast cancer 2, early onset (LOC584780), BRCA2, DNA repair associated (brca2), breast cancer 2, early onset (Brca2), 30169, AI256696, AW045498, BcDNA:SD25109, brca2, BRCA2, BRCC2, brcc2, BROVCA2, brovca2, CG13583, CG13584, CG30169, dmbrca2, Dmel\\CG30169, FACD, facd, FAD, fad, FAD1, fad1, FANCB, fancb, FANCD, FANCD1, fancd1, Fancd1, GLM3, PNCA2, RAB163

Protein level used designations for BRCA2

  • BRCA1/BRCA2-containing complex, subunit 2
  • breast and ovarian cancer susceptibility gene, early onset
  • breast cancer 2 tumor suppressor
  • breast cancer type 2 susceptibility protein
  • fanconi anemia group D1 protein
  • truncated breast and ovarian cancer susceptibility protein 2
  • breast cancer 2, early onset homolog
  • CG30169-PA
  • Brca2-PA
  • breast cancer 2, mutation 1, University of Wisconsin-Madison
  • breast cancer susceptibility protein 2
  • breast cancer type 2 susceptibility protein homolog
  • fanconi anemia group D1 protein homolog
  • breast and ovarian cancer susceptibility protein 2
  • breast cancer 2, early onset
  • breast cancer type 2 susceptibility protein-like
Vous êtes ici:
Support technique